Iintroduction: COVID-19 has increased opportunistic infections like mucormycosis, especially in immunocompromised individuals. Dentists play a key role in early detection and management of post-COVID oral complications, yet their awareness of mucormycosis remains underexplored. Objective: This study assesses dentists’ knowledge, attitudes, and practices regarding mucormycosis as a post-COVID orofacial complication. Methods: A cross-sectional study analyzed dentists’ demographics, awareness, and clinical practices on post-COVID mucormycosis. Data were statistically analyzed using SPSS 21.0. Results: Among participants, 81.6% had a fair understanding of post-COVID fungal infections, and 99.2% correctly identified mucormycosis. However, only 77.6% knew its diagnostic criteria. While 87% recognized mucormycosis as a complication, 72.8% identified rhino-orbital-cerebral mucormycosis as the most common type. Additionally, 73% were aware of treatment protocols, but only 17.8% had screened patients in the past year. Conclusion: Although dentists show strong awareness, gaps exist in clinical preparedness and diagnostic accuracy. Targeted training can enhance early detection, intervention, and multidisciplinary collaboration for better patient outcomes. © 2025 Elsevier B.V., All rights reserved.